1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Agomelatine Revenue
1.4 Market Analysis by Type
1.4.1 Global Agomelatine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Serotonin 2C Agonist
1.4.3 Melatonin Receptor 2 Agonist
1.4.4 Melatonin Receptor 1 Agonist
1.4.5 Serotonin Receptor Agonist
1.4.6 Serotonin 2C Receptor Antagonist
1.5 Market by Application
1.5.1 Global Agomelatine Market Share by Application: 2021-2026
1.5.2 Depression
1.5.3 Obsessive Compulsive Disorder
1.5.4 Sleep Disorders
1.5.5 Generalized Anxiety Disorder
1.5.6 Multiple Sclerosis
1.5.7 Systemic Traumatic Pain
1.5.8 Autism
1.5.9 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Agomelatine Market
1.8.1 Global Agomelatine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Agomelatine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Agomelatine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Agomelatine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Agomelatine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Agomelatine Sales Volume Market Share by Region (2015-2020)
3.2 Global Agomelatine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Agomelatine Sales Volume
3.3.1 North America Agomelatine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Agomelatine Sales Volume
3.4.1 East Asia Agomelatine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Agomelatine Sales Volume (2015-2020)
3.5.1 Europe Agomelatine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Agomelatine Sales Volume (2015-2020)
3.6.1 South Asia Agomelatine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Agomelatine Sales Volume (2015-2020)
3.7.1 Southeast Asia Agomelatine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Agomelatine Sales Volume (2015-2020)
3.8.1 Middle East Agomelatine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Agomelatine Sales Volume (2015-2020)
3.9.1 Africa Agomelatine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Agomelatine Sales Volume (2015-2020)
3.10.1 Oceania Agomelatine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Agomelatine Sales Volume (2015-2020)
3.11.1 South America Agomelatine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Agomelatine Sales Volume (2015-2020)
3.12.1 Rest of the World Agomelatine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Agomelatine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Agomelatine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Agomelatine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Agomelatine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Agomelatine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Agomelatine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Agomelatine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Agomelatine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Agomelatine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Agomelatine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Agomelatine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Agomelatine Sales Volume Market Share by Type (2015-2020)
14.2 Global Agomelatine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Agomelatine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Agomelatine Consumption Volume by Application (2015-2020)
15.2 Global Agomelatine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Agomelatine Business
16.1 Servier
16.1.1 Servier Company Profile
16.1.2 Servier Agomelatine Product Specification
16.1.3 Servier Agomelatine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Nectid Inc
16.2.1 Nectid Inc Company Profile
16.2.2 Nectid Inc Agomelatine Product Specification
16.2.3 Nectid Inc Agomelatine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Rovi Pharma
16.3.1 Rovi Pharma Company Profile
16.3.2 Rovi Pharma Agomelatine Product Specification
16.3.3 Rovi Pharma Agomelatine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Novartis
16.4.1 Novartis Company Profile
16.4.2 Novartis Agomelatine Product Specification
16.4.3 Novartis Agomelatine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Jiangsu Haosen Pharmaceutical Group
16.5.1 Jiangsu Haosen Pharmaceutical Group Company Profile
16.5.2 Jiangsu Haosen Pharmaceutical Group Agomelatine Product Specification
16.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Agomelatine Manufacturing Cost Analysis
17.1 Agomelatine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Agomelatine
17.4 Agomelatine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Agomelatine Distributors List
18.3 Agomelatine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Agomelatine (2021-2026)
20.2 Global Forecasted Revenue of Agomelatine (2021-2026)
20.3 Global Forecasted Price of Agomelatine (2015-2026)
20.4 Global Forecasted Production of Agomelatine by Region (2021-2026)
20.4.1 North America Agomelatine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Agomelatine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Agomelatine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Agomelatine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Agomelatine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Agomelatine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Agomelatine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Agomelatine Production, Revenue Forecast (2021-2026)
20.4.9 South America Agomelatine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Agomelatine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Agomelatine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Agomelatine by Country
21.2 East Asia Market Forecasted Consumption of Agomelatine by Country
21.3 Europe Market Forecasted Consumption of Agomelatine by Countriy
21.4 South Asia Forecasted Consumption of Agomelatine by Country
21.5 Southeast Asia Forecasted Consumption of Agomelatine by Country
21.6 Middle East Forecasted Consumption of Agomelatine by Country
21.7 Africa Forecasted Consumption of Agomelatine by Country
21.8 Oceania Forecasted Consumption of Agomelatine by Country
21.9 South America Forecasted Consumption of Agomelatine by Country
21.10 Rest of the world Forecasted Consumption of Agomelatine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer